Advertisement

Topics

Elekta, Inc. Company Profile

05:10 EST 17th February 2019 | BioPortfolio

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.


News Articles [13 Associated News Articles listed on BioPortfolio]

Elekta Unity, Elekta's Transformative Radiation Therapy Delivery System, Receives Good Design ...

CHICAGO, Jan. 9, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) and DCA Design International Ltd have won the Good Design® Award 2018 for Elekta Unity, a high-field Read more...

FDA clears Elekta's high-field MRI/linac system

The FDA has granted Sweden-based Elekta clearance to market its Elekta Unity high-field MRI/linac system, which combines a li -More- 

GenesisCare places order for Elekta’s magnetic resonance radiation therapy system

GenesisCare has developed a model for cancer care that is designed to enhance healthcare quality and access. The model will ensure that patients receive the right care when The post GenesisCare place...

Elekta: Blame It On Unity

Elekta AB 2019 Q2 - Results - Earnings Call Slides

Elekta AB ADR 2019 Q1 - Results - Earnings Call Slides

Elekta AB (EKTAY) CEO Richard Hausmann on Q1 2019 Results - Earnings Call Transcript

Elekta AB (EKTAF) CEO Richard Hausmann on Q2 2019 Results - Earnings Call Transcript

Drugs and Medications [0 Results]

None

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Monte Carlo and analytic modeling of an Elekta Infinity linac with Agility MLC: Investigating the significance of accurate model parameters for small radiation fields.

To explain the deviation observed between measured and Monaco calculated dose profiles for a small field (i.e., alternating open-closed MLC pattern). A Monte Carlo (MC) model of an Elekta Infinity lin...

Remote dosimetric auditing of clinical trials: The need for vendor specific models to convert images to dose.

A previous pilot study has demonstrated the feasibility of a novel image-based approach for remote dosimetric auditing of clinical trials. The approach uses a model to convert in-air acquired intensit...

A multicenter dosimetry study to evaluate the imaging dose from Elekta XVI and Varian OBI kV-CBCT systems to cardiovascular implantable electronic devices (CIEDs).

The increasing use of daily CBCT in radiotherapy has raised concerns about the additional dose delivered to the patient, and it can also become a concern issue for those patients with cardiovascular i...

A Usability Study of 3 Radiotherapy Systems: A Comparative Evaluation Based on Expert Evaluation and User Experience.

BACKGROUND The complex user interface design of radiotherapy treatment delivery systems can lead to use error and patient harm. In this study, we present the results of a comparison of 3 radiotherapy ...

Low-Dose Gamma Knife Radiosurgery for Acromegaly.

Remission rate is associated with higher dose of Gamma Knife Radiosurgery (GKRS; Gamma Knife: Elekta AB, Stockholm, Sweden) for acromegaly, but the dose ≥25 Gy is not always feasible when the functi...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients

The Christie NHS Foundation Trust is one of seven sites worldwide within the Atlantic consortium that is developing the Elekta MR-Linac (MRL) prior to commercial release at the end of 2017...

Companies [9 Associated Companies listed on BioPortfolio]

Elekta

Elekta is a human-care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-...

Elekta AB

Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders....

Elekta, Inc.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatme...

Elekta Inc.

CMS Software

CMS Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated sta...

More Information about "Elekta, Inc." on BioPortfolio

We have published hundreds of Elekta, Inc. news stories on BioPortfolio along with dozens of Elekta, Inc. Clinical Trials and PubMed Articles about Elekta, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elekta, Inc. Companies in our database. You can also find out about relevant Elekta, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record